On behalf of the Ministry of Health of the Republic of Kazakhstan, we ask you to take part in the sero-epidemiological study of COVID-19, which will be conducted in 2021 on the basis of our, as well as a number of other Kazakhstani universities.
By participating in the research, you will contribute to protecting the health of the country’s population.
This is a prospective observational study among students and faculty, which is being conducted by the Ministry of Health of the Republic of Kazakhstan with the support of the US Centers for Disease Control and Prevention.
The results of the study will provide the country with scientifically grounded data that will help determine the policy and practice for the safe transition of universities of the Republic of Kazakhstan from distance learning to full-time education. Decisions made on the basis of these results will go a long way in protecting the health of the general population.
Participants in the study will need to undergo a three-stage survey and laboratory testing for COVID-19 in February-March, May and October 2021. Conducting PCR and ELISA tests in three stages for all participants will help create a safe working environment in universities.
The study is being conducted to assess the degree and nature of the serological prevalence of antibodies to coronavirus 2 (SARS-CoV-2) among students and faculty of medical universities in comparison among persons who have been in contact with and have not been in contact with COVID-19 patients since March 2020. The study will examine the risk factors for infection, the relationship between seropositivity and symptoms, as well as the temporary resistance of antibodies over 9 months, knowledge, attitudes and practices of COVID-19.
Those wishing to take part in the study, please send your data in accordance with the attached form no later than March 5, 2021 to the email address firstname.lastname@example.org.
For all questions, you can contact the coordinators of this project from universities:
* Elmira Kaidar +7 707 101 95 77,